Picture of Lupin logo

LUPIN Lupin Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+4.51%
3m+32.53%
6m+21.38%
1yr+49.9%
Volume Change (%)
10d/3m-11.13%
Price vs... (%)
52w High-2.6%
50d MA+11.28%
200d MA+36.15%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)33.23
PEG Ratio (f)1.48
EPS Growth (f)28.95%
Dividend Yield (f)0.34%
Valuation (ttm)IndustryMarket
Price to Book Value7.19
Price to Tang. Book10.14
Price to Free Cashflow37.77
Price to Sales4.94
EV to EBITDA25.72

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital19.51%
Return on Equity16.92%
Operating Margin14.54%

Financial Summary

Year End 31st MarUnit202020212022202320242025E2026ECAGR / Avg
Total RevenueIN₹m153,747.6151,629.6164,054.8166,416.6200,108.2221,012.48246,293.466.41%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-87.75+1248.34-80.29+83.55+369.47+33.99+24.64n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202531st Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Lupin EPS forecast chart

Profile Summary

Lupin Limited is an India-based innovation-led transnational pharmaceutical company. The Company develops and commercializes a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions. The Company has a presence in the cardiovascular, anti-diabetic, and respiratory segments and has a significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS), and others. Its complex generics portfolio includes Filgrastim, Pegfilgrastim, Etanercept and Albuterol and others. Its biosimilar products include Lupifil (Filgrastim), Lupifil-P (Peg-Filgrastim) and Etanercept. Its diabetes brands include ONDERO and ONDERO MET. The Company has 15 manufacturing sites, seven research centers, and more than 20,000 professionals working globally.

Directors

Last Annual
March 31st, 2024
Last Interim
June 30th, 2024
Incorporated
March 1st, 1983
Public Since
November 30th, 1994
No. of Shareholders
286,705
No. of Employees
20,789
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
in flag iconNational Stock Exchange of India
Shares in Issue
456,137,419

LUPIN Share Price Performance

Upcoming Events for LUPIN

Lupin Ltd at Kotak Healthcare Forum

Q2 2025 Lupin Ltd Earnings Release

Q3 2025 Lupin Ltd Earnings Release

Similar to LUPIN

Picture of Aarey Drugs and Pharmaceuticals logo

Aarey Drugs and Pharmaceuticals

in flag iconNational Stock Exchange of India

Picture of Aarti Drugs logo

Aarti Drugs

in flag iconNational Stock Exchange of India

Picture of Aarti Pharmalabs logo

Aarti Pharmalabs

in flag iconNational Stock Exchange of India

Picture of Abbott India logo

Abbott India

in flag iconNational Stock Exchange of India

Picture of Accent Microcell logo

Accent Microcell

in flag iconNational Stock Exchange of India

FAQ